foxo4 dri senolytic peptide study 2017 cell inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI
FOXO4 DRI Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI For Lab Research Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21




